19-8589243-G-C
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_030957.4(ADAMTS10):c.2157C>G(p.Ala719Ala) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00557 in 1,612,584 control chromosomes in the GnomAD database, including 43 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A719A) has been classified as Uncertain significance.
Frequency
Consequence
NM_030957.4 splice_region, synonymous
Scores
Clinical Significance
Conservation
Publications
- Weill-Marchesani syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Weill-Marchesani syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -21 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_030957.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ADAMTS10 | NM_030957.4 | MANE Select | c.2157C>G | p.Ala719Ala | splice_region synonymous | Exon 18 of 26 | NP_112219.3 | ||
| ADAMTS10 | NM_001282352.2 | c.618C>G | p.Ala206Ala | splice_region synonymous | Exon 5 of 13 | NP_001269281.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ADAMTS10 | ENST00000597188.6 | TSL:5 MANE Select | c.2157C>G | p.Ala719Ala | splice_region synonymous | Exon 18 of 26 | ENSP00000471851.1 | ||
| ADAMTS10 | ENST00000270328.8 | TSL:5 | c.2157C>G | p.Ala719Ala | splice_region synonymous | Exon 17 of 25 | ENSP00000270328.4 | ||
| ADAMTS10 | ENST00000595838.5 | TSL:2 | c.618C>G | p.Ala206Ala | splice_region synonymous | Exon 5 of 13 | ENSP00000470501.1 |
Frequencies
GnomAD3 genomes AF: 0.00415 AC: 632AN: 152110Hom.: 2 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.00434 AC: 1075AN: 247862 AF XY: 0.00425 show subpopulations
GnomAD4 exome AF: 0.00572 AC: 8348AN: 1460356Hom.: 41 Cov.: 33 AF XY: 0.00575 AC XY: 4177AN XY: 726570 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00415 AC: 632AN: 152228Hom.: 2 Cov.: 31 AF XY: 0.00360 AC XY: 268AN XY: 74444 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:6
ADAMTS10: BP4, BP7, BS2
Weill-Marchesani syndrome Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at